Company Overview and News

 
Lodestar Minerals' shares soar on gold discovery

2017-12-27 proactiveinvestors.com.au
Lodestar Minerals Ltd's (ASX:LSR) shares are defying the normal quiet trading period, and have double in value to $0.018 with over 26 million changing hands.

 
Lodestar Minerals plans extensive drilling at Contessa gold prospect

2017-12-08 proactiveinvestors.com.au
Lodestar Minerals Limited (ASX:LSR) is planning a major drilling program at the Contessa gold prospect in Western Australia.

 
Lodestar Minerals concludes drilling at Contessa gold prospect

2016-11-07 proactiveinvestors.com.au
The 44-hole program for 3,490 metres at Contessa was designed to reduce the existing drill traverse spacing in areas of significant supergene mineralisation. The drilling specifically tested for structurally-controlled primary gold mineralisation near pre-existing drill traverses. Following completion of the drilling at Contessa, Lodestar completed an additional 13 holes at the Brumby prospect targeting a discrete magnetic anomaly.

 
Lodestar Minerals identifies potential gold targets at Ned’s Creek

2016-10-18 proactiveinvestors.com.au
The project is situated on the southern margin of the Plutonic Well greenstone belt, 36 kilometres northeast of the Plutonic gold mine. Lodestar’s geochemical sampling program is the first systematic exploration completed over these areas for almost 20 years. Assay results were received for more than 1,000 soil samples for the Marymia and West Pinnyriny prospects. Anomalous gold to a maximum of 61 ppb (parts per billion) gold was located in structural positions adjacent to lithological contacts and faults at Marymia.

 
Lodestar Minerals Ltd eyes near-surface gold at Contessa

2016-10-07 proactiveinvestors.com.au
Lodestar Minerals Ltd (ASX:LSR) will commence a 5,000 metre aircore drilling program designed to in-fill drill supergene (near-surface) gold mineralisation at the Contessa gold prospect. Contessa is located within Lodestar's wholly-owned Ned’s Creek project located 170 kilometres north of Meekatharra in Western Australia. The Contessa prospect is a large composite granite intrusion that displays extensive surface gold anomalism.

 
Lodestar Minerals Ltd eyes near-surface gold at Contessa

2016-10-05 proactiveinvestors.com.au
Lodestar Minerals Ltd (ASX:LSR) will commence a 5,000 metre aircore drilling program designed to in-fill drill supergene (near-surface) gold mineralisation at the Contessa gold prospect. Contessa is located within Lodestar's wholly-owned Ned’s Creek project located 170 kilometres north of Meekatharra in Western Australia. The Contessa prospect is a large composite granite intrusion that displays extensive surface gold anomalism.

 
Lodestar Minerals Ltd to lift the lid on Contessa

2016-07-20 proactiveinvestors.com.au
Lodestar Minerals Ltd (ASX:LSR) is a West Australian exploration company focussed on the discovery of copper and gold.

 
Lodestar Minerals Ltd to reveal Contessa gold drilling results

2016-07-20 proactiveinvestors.com.au
Lodestar Minerals Ltd (ASX:LSR) is a West Australian exploration company focussed on the discovery of copper and gold.

 
Response to ASX Aware Letter

2016-03-31 asx.com.au

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

20h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

20h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...